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background: Individual platelet response to antiplatelet therapy depends on genetic, cellular and clinical factors. We evaluated the effect of 
vascular function on platelet activation in patients after percutaneous coronary intervention (PCI) treated with dual antiplatelet therapy.
methods: We consecutively enrolled 408 patients with stable coronary artery disease one month after successful PCI. All subjects were receiving 
dual antiplatelet therapy with aspirin (100mg/day) and clopidogrel (75mg/day) for at least one month at the time we evaluated their platelet 
reactivity and arterial function. Carotid-femoral pulse wave velocity (PWV) was measured as an index of aortic stiffness and augmentation index (AIx) 
as an index of arterial wave reflections. High on treatment platelet reactivity was evaluated using VerifyNow Assay. VerifyNow reports its results in 
P2Y12 reaction units (PRU) and the diagnostic cut-off value is 230 PRU.
results: Importantly, subjects with high on treatment platelet reactivity and PRU>230 had significantly increased PWV (8.81±2.25 m/sec vs. 
7.69±1.95 m/sec, p=0.001) and AIx (25.27±8.67 % vs. 20.87±10.57 %, p=0.04) compared to subjects with PRU≤230.
conclusions: We documented an association between a direct measurement of platelet activation and vascular function in patients after PCI 
treated with clopidogrel regimen. As platelet reactivity is associated with long-term cardiovascular events after PCI the introduction of another 
clinical factor implicated in the variability of individual platelet response to antiplatelet therapy is of great importance.
